Claris Lifesciences

New York-based PE firm picks up stake in Carlyle-backed Claris Lifesciences for $4M

24 July, 2012

New York-based private equity firm Signet Healthcare Partners has picked up a little over 2 per cent stake in Carlyle-backed pharmaceutical company Claris Lifesciences. The deal, which would be the first transaction by the firm in an India-based company, has seen Signet picking up 2.2 per cent stake in Claris for Rs 22.78 crore ($4.13 million).


Leave Your Comment
Carlyle-backed Claris selling infusion biz to Otsuka and Mitsui for $194M

Carlyle-backed Claris selling infusion biz to Otsuka and Mitsui for $194M

Bruhadeeswaran R 5 years ago
Claris Lifesciences Ltd is selling majority stake in its infusion business in India and other emerging markets by forming a three party joint venture with...
Carlyle-backed Claris Lifesciences comes up with buyback offer, promoters to participate

Carlyle-backed Claris Lifesciences comes up with buyback offer, promoters to participate

Lohit Jagwani 4 years ago
Ahmedabad-based pharmaceutical company Claris Lifesciences Ltd has received a go-ahead from its board to launch a buyback of shares representing up to 14.5 per cent...
Healthcare-focused investor OrbiMed buys stake in Claris Lifesciences

Healthcare-focused investor OrbiMed buys stake in Claris Lifesciences

Madhav A Chanchani 4 years ago
A fund managed by the private equity firm OrbiMed Advisors has picked up close to 3 per cent stake in Carlyle-backed pharmaceutical company Claris Lifesciences...
No Comments

New York-based PE firm picks up stake in Carlyle-backed Claris Lifesciences for $4M

Powered by WordPress.com VIP